Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
2.
Social Science Open Access Repository; 2020.
Non-conventional in English | Social Science Open Access Repository | ID: grc-748107

ABSTRACT

Before the COVID-19 pandemic, the European Union (EU) was neither a strong pro

3.
Social Science Open Access Repository; 2020.
Non-conventional in German | Social Science Open Access Repository | ID: grc-748106

ABSTRACT

Vor der Covid‑19-Pandemie galt die Europäische Union (EU) weder als Motor für globale Gesundheit noch als bedeutende Unterstützerin der Weltgesundheits

4.
Social Science Open Access Repository; 2020.
Non-conventional in German | Social Science Open Access Repository | ID: grc-747869

ABSTRACT

Deutschland übernimmt in der zweiten Jahreshälfte 2020 die EU-Ratspräsidentschaft. Im Trio mit Portugal und Slowenien, die in dieser Funktion nachfolgen werden, sollte die Bundesregierung den Vorsitz nutzen, um die Rolle der EU in der globalen Gesund

5.
Social Science Open Access Repository; 2020.
Non-conventional in English | Social Science Open Access Repository | ID: grc-747866

ABSTRACT

The Covid-19 pandemic has made policy-makers aware of the challenges of maintaining quality health care in times of crisis. Strengthening health systems is the key to meeting these challenges. The implementation of the Global Compact for Safe, Orderly and Regular Migration (GCM), agreed in December 2018, can make an important con

6.
Social Science Open Access Repository; 2020.
Non-conventional in English | Social Science Open Access Repository | ID: grc-747818

ABSTRACT

In the second half of 2020, Germany will take over the Council Presidency of the Euro

7.
Social Science Open Access Repository; 2020.
Non-conventional in German | Social Science Open Access Repository | ID: grc-747738

ABSTRACT

Die Covid-19-Pandemie hat politische Entscheidungsträger dafür sensibilisiert, welche Herausforderungen es mit sich bringt, in Krisenzeiten die gesundheitliche Regelversor

9.
BMJ Glob Health ; 5(11)2020 11.
Article in English | MEDLINE | ID: covidwho-944936

ABSTRACT

INTRODUCTION: Public health decision-making requires the balancing of numerous, often conflicting factors. However, participatory, evidence-informed decision-making processes to identify and weigh these factors are often not possible- especially, in the context of the SARS-CoV-2 pandemic. While evidence-to-decision frameworks are not able or intended to replace stakeholder participation, they can serve as a tool to approach relevancy and comprehensiveness of the criteria considered. OBJECTIVE: To develop a decision-making framework adapted to the challenges of decision-making on non-pharmacological interventions to contain the global SARS-CoV-2 pandemic. METHODS: We employed the 'best fit' framework synthesis technique and used the WHO-INTEGRATE framework as a starting point. First, we adapted the framework through brainstorming exercises and application to case studies. Next, we conducted a content analysis of comprehensive strategy documents intended to guide policymakers on the phasing out of applied lockdown measures in Germany. Based on factors and criteria identified in this process, we developed the WICID (WHO-INTEGRATE COVID-19) framework version 1.0. RESULTS: Twelve comprehensive strategy documents were analysed. The revised framework consists of 11+1 criteria, supported by 48 aspects, and embraces a complex systems perspective. The criteria cover implications for the health of individuals and populations due to and beyond COVID-19, infringement on liberties and fundamental human rights, acceptability and equity considerations, societal, environmental and economic implications, as well as implementation, resource and feasibility considerations. DISCUSSION: The proposed framework will be expanded through a comprehensive document analysis focusing on key stakeholder groups across the society. The WICID framework can be a tool to support comprehensive evidence-informed decision-making processes.


Subject(s)
COVID-19 , Decision Making , Global Health , Public Health , World Health Organization , COVID-19/prevention & control , COVID-19/therapy , Humans , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL